Bio-Works Technologies
2,37 SEK
+2,60 %
Mindre end 1K følgere
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
+2,60 %
-10,23 %
-23,30 %
+29,51 %
+146,11 %
+169,62 %
-83,82 %
-60,79 %
-72,42 %
Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
Læs mereMarkedsværdi
232,79 mio. SEK
Aktieomsætning
149,42 t SEK
Omsætning
25,47 mio.
EBIT %
-149,2 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
20.2
2026
Årsrapport '25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Bio-Works Technologies AB: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe
Bio-Works Technologies AB: Bio-Works forms strategic partnership with Zenmindes Biotechnology to strengthen presence in China
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer